Company on track to report ELEVATE-44-201 data from the first cohort in Q2 2026 and ELEVATE-45-201 data from the first cohort in mid-2026 – -- Expects to initiate global Phase 1/2 MAD clinical study o ...
Researchers have developed a new computational approach that uncovers possible drugs for specific cellular targets for ...
Researchers have developed a new computational approach that uncovers possible drugs for specific cellular targets for treating glioblastoma, a lethal brain tumor.  This approach enabled them to ...
Swedish scientists retrieved RNA from an extinct Tasmanian tiger to help trace the genes that were active in the animal’s ...